Pulnovo Medical Raises Tens of Millions in New Financing Round
Wuxi-based Pulnovo Medical Limited, a developer of medical devices for hypertension and heart failure, announced...
PHASE Scientific Completes Series A Financing to Advance Urine-Based Diagnostics
Hong Kong-based urine-based diagnostics specialist PHASE Scientific International Limited announced the completion of a Series...
China’s CDE Announces 94th Batch of Reference Preparations for Generic Evaluation
China’s Center for Drug Evaluation (CDE) has selected the 94th batch of reference preparations for...
Merck KGaA Partners with IMEC to Develop Advanced Microphysiological Systems Platform
German major Merck KGaA (ETR: MRK) this week announced a partnership with Belgium-based Interuniversity Microelectronics Centre...
Antengene and MSD Collaborate on ATG-022 for Advanced Solid Tumors
China-based Antengene Corporation Limited (HKG: 6996) has entered into a collaboration with US major Merck,...
China’s County Hospitals Show Improved Medical Service Capability in 2024
The National Health Commission (NHC) released a notice reporting the status of the county hospital...
3SBio Registers Phase III Study for SSGJ-707 in Advanced NSCLC
China-based 3SBio Inc. (HKG: 1530) announced this week the registration of the first Phase III...
Ascletis Pharma Initiates ASC47-103 Study in US for Obesity Treatment
China-based Ascletis Pharma Inc. (HKG: 1672) announced the first subject dosing of the ASC47-103 study...
Yifan Pharma Licenses Ryzneuta to Lenis for Balkan Markets
China-based Yifan Pharmaceutical Co., Ltd (SHE: 002019) announced a licensing agreement with Lenis, a Slovenian-based...
Abbisko’s Pimitinib Granted Priority Review for TGCT Treatment in China
Abbisko Therapeutics Co., Ltd (HKG: 2256) announced that its self-developed, highly selective small-molecule CSF-1R inhibitor,...
Minghui Pharmaceutical Launches Phase II Study of Combination Therapy for Advanced NSCLC
China-based Minghui Pharmaceutical Inc. announced the initiation of a Phase II clinical study to evaluate...
CSPC Pharmaceutical Gains NMPA Approval for JMT106 Clinical Study in Solid Tumors
China-based CSPC Pharmaceutical Group Ltd (HKG: 1093) announced that it has received approval from the...
Zhaoke Ophthalmology’s Cyclosporine Eye Gel NDA Accepted by NMPA
China-based Zhaoke Ophthalmology Ltd (HKG: 6622) announced that the New Drug Application (NDA) for its...
Johnson & Johnson MedTech Completes First PFA Surgeries with VARIPULSE Catheter in China
US-based Johnson & Johnson MedTech announced the completion of the first batch of pulse electric...
Shanghai CureGene Completes Series B+ Financing to Advance CG-0255 Study
China-based Shanghai CureGene Pharmaceutical Co., Ltd announced the completion of a Series B+ financing round,...
Regeneron Wins Auction for 23andMe’s Core Business Units
US-based biopharma Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) announced this week that it has successfully bid...
GSK’s Blenrep Receives Marketing Approval in Japan for Multiple Myeloma
UK-based pharmaceutical giant GlaxoSmithKline (GSK, NYSE: GSK) announced that it has received marketing approval from...
Accurate Biotechnology Secures RMB 100M in Series B Funding for Organoid Technology
Accurate Biotechnology, a Guangzhou-based biotech focused on organoid technology, reportedly raised RMB 100 million (USD...
Hainan Shuangcheng’s Generic Eptifibatide Gains TGA Marketing Approval in Australia
China’s Hainan Shuangcheng Pharmaceutical Co., Ltd (SHE: 002693) has received marketing approval from Australia’s Therapeutic...
Stryker’s OptaBlate BVN System Gains FDA 510(k) Clearance
US-based Stryker (NYSE: SYK) announced this week that its OptaBlate Basivertebral Nerve Ablation (BVN) system...